Evidence map›Paper›PMID 38512257›Full record

ArticleJAMA network open2024

Prevalence of Lung Cancer Screening in the US, 2022.

Louise M Henderson, I-Hsuan Su, M Patricia Rivera, Joyce Pak, Xiaomeng Chen, Daniel S Reuland, Jennifer L Lund

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Variability Among Radiologists in Interpreting Low-Dose CT Lung Cancer Screens.Journal of the American College of Radiology : JACR · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Improving lung cancer screening diagnostic efficiency.Current opinion in pulmonary medicine · 2026
    Review
  18. Exploring Clinical Pathways to a Metastatic Lung Cancer Diagnosis: A Latent Class Analysis Using North Carolina Multipayer Claims Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Louise M HendersonDepartment of Radiology, University of North Carolina at Chapel Hill.
I-Hsuan SuDepartment of Epidemiology, University of North Carolina at Chapel Hill.
M Patricia RiveraDepartment of Medicine, University of Rochester Medical Center, Rochester, New York.
Joyce PakDepartment of Epidemiology, University of North Carolina at Chapel Hill.
Xiaomeng ChenDepartment of Epidemiology, University of North Carolina at Chapel Hill.
Daniel S ReulandLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
Jennifer L LundLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.

Funding

Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina RegistryR01CA212014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Louise Henderson · 2017 to 2026
$5.4M
Comorbidity and Functional Status in a Population Undergoing Lung Cancer ScreeningR01CA251686 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HENDERSON, LOUISE, RIVERA, MARIA PATRICIA · 2020 to 2023
$1.5M
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening - NCI Diversity SupplementR01CA277756 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Louise Henderson, Jennifer Lund · 2023 to 2026
$1.5M
NCI NIH HHS R01 CA212014NCI NIH HHS R01 CA251686NCI NIH HHS R01 CA277756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Detection of CancerLung NeoplasmsHumansPrevalence

Identifiers

PMID38512257
PMCPMC10958241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.